IL18 and small cell lung carcinoma: In addition to its effects on the TME, IL-18 strongly stimulated the proliferation, persistence, and memory phenotype of human DLL3 CAR T cells and reduced their exhaustion, leading to long-term remission in 3 different SCLC models.